Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

TRPS1 expression is sensitive and specific for primary extramammary Paget disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Oxford, Blackwell Scientific Publications.
    • الموضوع:
    • نبذة مختصرة :
      Aims: Extramammary Paget disease (EMPD) is an epithelial neoplasm that can occur at many sites, including the vulva and scrotum. EMPD is characterised by the presence of neoplastic cells, in single cells and clusters, that infiltrate all layers of non-neoplastic squamous epithelium. The differential diagnosis for EMPD includes melanoma in situ and secondary involvement of tumours from other sites, such as urothelial or cervical; pagetoid spread of tumor cells can also been seen at other sites, such as anorectal mucosa. The most frequently utilised biomarkers for confirming the diagnosis of EMPD include CK7 and GATA3; however, these biomarkers lack specificity. The purpose of this study was to evaluate TRPS1, a newly described breast biomarker, in pagetoid neoplasms of the vulva, scrotum and anorectum.
      Methods and Results: Fifteen cases of primary EMPD of the vulva (two with associated invasive carcinoma) and four primary EMPD of the scrotum showed strong nuclear immunoreactivity for TRPS1. In contrast, five cases of vulvar melanoma in situ, one case of urothelial carcinoma with secondary pagetoid spread into the vulva and two anorectal adenocarcinomas with pagetoid spread into anal skin (one with associated invasive carcinoma) were negative for TRPS1. Additionally, weak nuclear TRPS1 staining was observed in non-neoplastic tissues (e.g. keratinocytes), but always with less intensity when compared to tumour cells.
      Conclusions: These results demonstrate that TRPS1 is a sensitive and specific biomarker for EMPD, and may be especially useful for excluding secondary involvement of the vulva by urothelial and anorectal carcinomas.
      (© 2023 John Wiley & Sons Ltd.)
    • References:
      van der Linden M, Meeuwis KA, Bulten J et al. Paget disease of the vulva. Crit. Rev. Oncol. Hematol. 2016; 101; 60-74.
      van der Linden M, Oonk MHM, van Doorn HC et al. Vulvar Paget disease: a national retrospective cohort study. J. Am. Acad. Dermatol. 2019; 81; 956-962.
      Hill SJ, Berkowitz R, Granter SR, Hirsch MS. Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease. Int. J. Gynecol. Pathol. 2008; 27; 292-296.
      Shaco-Levy R, Bean SM, Vollmer RT et al. Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course. Int. J. Gynecol. Pathol. 2010; 29; 69-78.
      Zhao M, Zhou L, Sun L et al. GATA3 is a sensitive marker for primary genital extramammary Paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15. Diagn. Pathol. 2017; 12(1); 51.
      Kajtezovic S, Walker AR, Hjalmarsson B, Bell SG, Everett E, Wong C. Management of secondary Paget's disease of the vulva associated with transitional cell carcinoma. J. Cancer Res. Clin. Oncol. 2022; 148; 1697-1702.
      Yanai H, Takahashi N, Omori M et al. Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease. Pathol. Int. 2008; 58; 648-651.
      Al-Obaidy KI, Kao CS, Idrees MT. P16 expression in extramammary Paget's disease of the vulva and scrotum is not human papillomavirus related. Int. J. Surg. Pathol. 2018; 26; 617-620.
      Sah SP, McCluggage WG. Florid vulval Paget disease exhibiting p16 immunoreactivity and mimicking classic VIN. Int. J. Gynecol. Pathol. 2013; 32; 221-227.
      Radvanyi L, Singh-Sandhu D, Gallichan S et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc. Natl. Acad. Sci. USA 2005; 102; 11005-11010.
      Parkinson B, Chen W, Shen T, Parwani AV, Li Z. TRPS1 expression in breast carcinomas: focusing on metaplastic breast carcinomas. Am. J. Surg. Pathol. 2022; 46; 415-423.
      Ai D, Yao J, Yang F et al. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod. Pathol. 2021; 34; 710-719.
      Yoon EC, Wang G, Parkinson B et al. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum. Pathol. 2022; 125; 97-107.
      Hu J, Zhang H, Liu L, Han B, Zhou G, Su P. TRPS1 confers multidrug resistance of breast cancer cells by regulating BCRP expression. Front. Oncol. 2020; 30; 934.
      Cho WC, Ding Q, Wang WL et al. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J. Cutan. Pathol. 2023. [Epub, ahead of print].
    • Contributed Indexing:
      Keywords: Paget; TRPS1; extramammary; melanoma; pagetoid; vulva
    • الرقم المعرف:
      0 (Biomarkers, Tumor)
      0 (TRPS1 protein, human)
      0 (Repressor Proteins)
    • الموضوع:
      Date Created: 20230327 Date Completed: 20230619 Latest Revision: 20231213
    • الموضوع:
      20240829
    • الرقم المعرف:
      10.1111/his.14908
    • الرقم المعرف:
      36971374